X0206 3 2017-02-15 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001697798 Hibben Edward K. C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ, BLDG 1400E, STE B14202 CAMBRIDGE MA 02139 0 1 0 0 Chief Business Officer Stock Option (right to buy) 11.05 2025-04-29 Common Stock 77042 D Stock Option (right to buy) 4.57 2026-02-10 Common Stock 30000 D Stock Option (right to buy) 4.31 2026-09-07 Common Stock 40000 D Stock Option (right to buy) 1.24 2027-02-08 Common Stock 100000 D This option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of April 15, 2015 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. This option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 11, 2016 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. This option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of September 8, 2016 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. This option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 9, 2017 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. Edward K. Hibben 2017-02-17